These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2257570)

  • 21. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
    Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
    Shearman JD; Yin ZG; Aarons I; Smith PS; Woodroffe AJ; Clarkson AR
    Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunosuppressive therapy for idiopathic membranous glomerulopathy].
    Branten AJ; Wetzels JF
    Ned Tijdschr Geneeskd; 1998 Apr; 142(14):767-72. PubMed ID: 9646608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
    Kibriya MG; Tishkov I; Nikolov D
    Nephrol Dial Transplant; 1994; 9(2):138-43. PubMed ID: 8190328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2006 Feb; 21(2):389-96. PubMed ID: 16234291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
    J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
    J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
    Hofstra JM; Wetzels JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3534-8. PubMed ID: 18559961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
    Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Willems HL; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO; Gucer S; Tinaztepe K
    Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of steroid therapy in different stages of membranous nephropathy.
    Fuiano G; Stanziale P; Balletta M; Sepe V; Marinelli G; Comi N; Esposito A; Andreucci VE
    Nephrol Dial Transplant; 1989; 4(12):1022-9. PubMed ID: 2517322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic membranous nephropathy in the elderly.
    Passerini P; Como G; Viganò E; Melis P; Pozzi C; Altieri P; Ponticelli C
    Nephrol Dial Transplant; 1993; 8(12):1321-5. PubMed ID: 8159299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
    Haas M; Mayer G; Wirnsberger G; Holzer H; Ratschek M; Neyer U; Neuweiler J; Kramar R; Schneider B; Breiteneder-Geleff S; Regele HM; Hörl WH; Kerjaschki D
    Wien Klin Wochenschr; 2002 Feb; 114(4):143-7. PubMed ID: 12060980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.